Inside the PVI Trials Book 2025: PAD trials with Prof. Brodmann & Dr. Lobato

Dr. Marta Lobato recently conducted an in-depth interview with Prof. Marianne Brodmann to discuss the upcoming PVI Trials Book 2025, a must-have reference for vascular specialists that compiles the latest studies and RCTs across all areas of vascular medicine.

As the author of the Peripheral Artery Disease (PAD) chapter, Prof. Brodmann highlights key trials and meta-analyses covering drug-eluting technologies, including paclitaxel- and limus-coated devices, scaffolding, and other emerging innovations. She explains how this new edition helps physicians quickly identify what’s new, what works, and what to expect in clinical practice.

Among the studies discussed, she mentions the SIRONA trial — the first head-to-head comparison of paclitaxel-coated versus limus-coated DCBs — and its potential to shape future treatment strategies. Although the trial is not included in the 2025 edition of the PVI Trials Book, as published results are not yet available, it remains one of the most anticipated investigations in the PAD field.

Prof. Brodmann also underscores the importance of ongoing research into bioresorbable technologies and drug-device combinations to optimise long-term patient outcomes.

This interview is essential viewing for anyone wishing to stay up to date with the latest PAD trials and make informed, evidence-based decisions in vascular care.

Watch the full interview to hear Prof. Brodmann and Dr. Lobato discuss the newest insights from the PAD chapter of the PVI Trials Book 2025.